D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

The increasing demand for AI-driven infrastructure and robust digital transformation initiatives are fueling this growth. Key ...

Highlights include Changan's SDA middleware, NIO's SkyOS, and the integration of AI foundation models into vehicle systems. By 2025, this evolution will enhance software-driven vehicle capabilities, ...

Boston Institute of Analytics upgrades its Data Science Program in Boston with Generative AI, LLMs, Prompt Engineering, and real-world AI projects. BOSTON, MA, UNITED STATES, May 5, 2025 /EINPresswire ...